Changliang Xu

2.0k total citations · 2 hit papers
54 papers, 1.5k citations indexed

About

Changliang Xu is a scholar working on Molecular Biology, Biomaterials and Hematology. According to data from OpenAlex, Changliang Xu has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Biomaterials and 9 papers in Hematology. Recurrent topics in Changliang Xu's work include Wound Healing and Treatments (8 papers), Electrospun Nanofibers in Biomedical Applications (7 papers) and Hemostasis and retained surgical items (6 papers). Changliang Xu is often cited by papers focused on Wound Healing and Treatments (8 papers), Electrospun Nanofibers in Biomedical Applications (7 papers) and Hemostasis and retained surgical items (6 papers). Changliang Xu collaborates with scholars based in China, United States and Mexico. Changliang Xu's co-authors include Xiaoying Wang, Zhengguo Wu, Wei Zhou, Weijie Deng, Haibo Cheng, Weixing Shen, Xiaoying Wang, Jiani Tan, Chunsheng Pang and Xiaoyun Li and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Changliang Xu

54 papers receiving 1.5k citations

Hit Papers

Antibacterial and Hemostatic Thiol-Modified Chitosan-Immo... 2020 2026 2022 2024 2020 2024 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antibacterial and Hemostatic Thiol-Modified Chitosan-Immobilized AgNPs Composite Sponges
    2020 213 citations Zhengguo Wu, Wei Zhou et al. profile →
  2. Sprayable and self-healing chitosan-based hydrogels for promoting healing of infected wound via anti-bacteria, anti-inflammation and angiogenesis
    2024 60 citations Changliang Xu, Xiaoying Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changliang Xu China 21 448 408 394 226 205 54 1.5k
Yunquan Zheng China 24 462 1.0× 574 1.4× 509 1.3× 428 1.9× 142 0.7× 57 1.9k
Anna Calarco Italy 25 400 0.9× 398 1.0× 517 1.3× 84 0.4× 152 0.7× 68 1.7k
Hnin Ei Thu Malaysia 26 589 1.3× 848 2.1× 592 1.5× 515 2.3× 226 1.1× 50 2.7k
Sandra Simões Portugal 30 239 0.5× 317 0.8× 616 1.6× 261 1.2× 209 1.0× 83 2.7k
Yanling Zhou China 23 283 0.6× 271 0.7× 598 1.5× 177 0.8× 52 0.3× 50 1.4k
Q. N. Xu China 19 580 1.3× 443 1.1× 359 0.9× 461 2.0× 275 1.3× 37 1.6k
Xianai Shi China 22 503 1.1× 569 1.4× 435 1.1× 429 1.9× 88 0.4× 72 1.6k
Raghuram Kandimalla India 26 309 0.7× 389 1.0× 552 1.4× 141 0.6× 230 1.1× 59 1.6k
Yan Yang China 24 323 0.7× 452 1.1× 428 1.1× 89 0.4× 106 0.5× 82 1.6k
Shuyan Han China 20 516 1.2× 597 1.5× 335 0.9× 483 2.1× 150 0.7× 40 1.7k

Countries citing papers authored by Changliang Xu

Since Specialization
Citations

This map shows the geographic impact of Changliang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changliang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changliang Xu more than expected).

Fields of papers citing papers by Changliang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changliang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changliang Xu. The network helps show where Changliang Xu may publish in the future.

Co-authorship network of co-authors of Changliang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Changliang Xu. A scholar is included among the top collaborators of Changliang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changliang Xu. Changliang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Hui, Yingjie Xu, Changliang Xu, et al.. (2025). Network pharmacology alliance with experimental validation unveils the anti-colorectal cancer mechanism of Xianlian Jiedu decoction. Journal of Ethnopharmacology. 342. 119361–119361. 1 indexed citations
2.
Xu, Changliang, et al.. (2025). From Pathophysiology to Treatment: The Role of Ferroptosis in PCOS. Frontiers in Bioscience-Landmark. 30(2). 25586–25586. 2 indexed citations
3.
Zhang, Y., Meng Shen, Jie Jin, et al.. (2025). Shen-Bai-Jie-Du decoction inhibits colorectal tumorigenesis by attenuating the malignancy of cancer stem cells via the gut microbiota-bile acid-FXR axis. Phytomedicine. 148. 157366–157366. 1 indexed citations
4.
Huang, Min, Y. Zhang, Meng Shen, et al.. (2024). Shen-Bai-Jie-Du decoction suppresses the progression of colorectal adenoma to carcinoma through regulating gut microbiota and short-chain fatty acids. Chinese Medicine. 19(1). 149–149. 4 indexed citations
5.
Lai, Yueyang, Liu Li, Jiani Tan, et al.. (2024). Sophocarpine alleviates intestinal fibrosis via inhibition of inflammation and fibroblast into myofibroblast transition by targeting the Sirt1/p65 signaling axis. European Journal of Pharmacology. 967. 176318–176318. 4 indexed citations
6.
Hu, Wenlong, Jie Shen, Tao Yu, et al.. (2023). CCDC85C suppresses colorectal cancer cells proliferation and metastasis through activating GSK-3β and promoting β-catenin degradation. Cellular Signalling. 109. 110799–110799. 1 indexed citations
7.
8.
9.
Yu, Chengtao, Wenlong Hu, Dongdong Sun, et al.. (2022). Identification of Significant Modules and Targets of Xian-Lian-Jie-Du Decoction Based on the Analysis of Transcriptomics, Proteomics and Single-Cell Transcriptomics in Colorectal Tumor. SHILAP Revista de lepidopterología. 18 indexed citations
10.
Li, Shanshan, Bin Gu, Xiaoyun Li, et al.. (2022). MXene‐Enhanced Chitin Composite Sponges with Antibacterial and Hemostatic Activity for Wound Healing (Adv. Healthcare Mater. 12/2022). Advanced Healthcare Materials. 11(12). 9 indexed citations
11.
Liu, Jianrong, Ke Fei, Tingting Chen, et al.. (2020). MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer: a systematic review. Journal of Cancer Research and Clinical Oncology. 146(4). 809–820. 25 indexed citations
12.
Li, Liu, Ji Yi, Junting Fan, et al.. (2019). Demethylzeylasteral (T-96) inhibits triple-negative breast cancer invasion by blocking the canonical and non-canonical TGF-β signaling pathways. Naunyn-Schmiedeberg s Archives of Pharmacology. 392(5). 593–603. 24 indexed citations
13.
Wu, Zhengguo, Wei Zhou, Chunsheng Pang, et al.. (2019). Multifunctional chitosan-based coating with liposomes containing laurel essential oils and nanosilver for pork preservation. Food Chemistry. 295. 16–25. 141 indexed citations
14.
Sun, Dongdong, Feng Zhang, Jie Qian, et al.. (2018). 4′-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling. Chemico-Biological Interactions. 296. 26–33. 21 indexed citations
15.
Sun, Dongdong, Weixing Shen, Feng Zhang, et al.. (2018). α-Hederin Arrests Cell Cycle at G2/M Checkpoint and Promotes Mitochondrial Apoptosis by Blocking Nuclear Factor-κB Signaling in Colon Cancer Cells. BioMed Research International. 2018. 1–11. 16 indexed citations
16.
Sun, Dongdong, Xiaofang Xu, Weixing Shen, et al.. (2017). LC-MS/MS analysis and evaluation of the anti-inflammatory activity of components from BushenHuoxue decoction. Pharmaceutical Biology. 55(1). 937–945. 20 indexed citations
17.
Tan, Jiani, Weixing Shen, Wenjing Shi, et al.. (2017). ONTD induces growth arrest and apoptosis of human hepatoma Bel-7402 cells though a peroxisome proliferator-activated receptor γ-dependent pathway. Toxicology in Vitro. 45(Pt 1). 44–53. 8 indexed citations
18.
Jin, Yuqin, Jialing Li, Jindong Chen, Changliang Xu, & Li Huang. (2017). Dalbergioidin (DAL) protects MC3T3-E1 osteoblastic cells against H2O2-induced cell damage through activation of the PI3K/AKT/SMAD1 pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 390(7). 711–720. 7 indexed citations
19.
Xu, Changliang, et al.. (2013). Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats. Fitoterapia. 90. 112–118. 61 indexed citations
20.
Han, Bing, et al.. (2013). Numerical Simulation and Experimental of Residual Stress Field of SAE1070 Spring Steel Induced by Laster Shock. Research Journal of Applied Sciences Engineering and Technology. 5(20). 4869–4877. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunquan Zheng Breakdown of academic impact, for papers by Anna Calarco Breakdown of academic impact, for papers by Hnin Ei Thu Breakdown of academic impact, for papers by Sandra Simões Breakdown of academic impact, for papers by Yanling Zhou Breakdown of academic impact, for papers by Q. N. Xu Breakdown of academic impact, for papers by Xianai Shi Breakdown of academic impact, for papers by Raghuram Kandimalla Breakdown of academic impact, for papers by Yan Yang Breakdown of academic impact, for papers by Shuyan Han
Rankless by CCL
2026